Skip to Content

BMD 110 G (Canada)

This page contains information on BMD 110 G for veterinary use.
The information provided typically includes the following:
  • BMD 110 G Indications
  • Warnings and cautions for BMD 110 G
  • Direction and dosage information for BMD 110 G

BMD 110 G

This treatment applies to the following species:
Company: Zoetis


DIN 02206099

Medicated Bacitracin Methylene Disalicylate Premix

Veterinary Use Only

For Feed Manufacturing Use Only

Active Ingredient: Bacitracin Methylene Disalicylate equivalent to Bacitracin 110 g/kg

For manufacturing complete feeds for broiler chickens, pregnant and lactating sows or gilts.


A dried precipitated fermentation product obtained by culturing Bacillus licheniformis tracy on media adapted for microbiological production of bacitracin; calcium carbonate. Granular antibiotic product.

BMD 110 G Indications And Directions For Use

To reduce the development of antimicrobial resistance and maintain effectiveness, use this antibiotic prudently and for the shortest duration required to achieve the desired clinical outcome.

Broiler chickens for reduction of early mortality due to diminished feed consumption and chilling:

Feed to 1 week of age.

1.0 kg of BMD® 110 G per 999.0 kg complete feed to provide a bacitracin concentration of 110 mg/kg.

Broiler chickens for prevention of necrotic enteritis caused by Clostridium perfringens susceptible to bacitracin:

Feed continuously to market weight.

0.5 kg of BMD® 110 G per 999.5 kg complete feed to provide a bacitracin concentration of 55 mg/kg.

Broiler chickens as an aid in treatment of necrotic enteritis associated with Clostridium perfringens susceptible to bacitracin. Start medication at first clinical signs of disease.

Feed continuously for 7 days.

1.0 kg of BMD® 110 G per 999.0 kg complete feed to provide a bacitracin concentration of 110 mg/kg.

Pregnant and lactating sows or gilts:

Feed for 2 1/2 weeks before farrowing through 3 weeks after farrowing for prevention of clostridial enteritis in suckling piglets caused by Clostridium spp. susceptible to bacitracin. Clostridial enteritis in piglets has a low incidence in Canada.

2.5 kg of BMD® 110 G per 997.5 kg complete feed to provide a bacitracin concentration of 275 mg/kg.


No withdrawal period is required when treated according to the label. When handling the product, avoid inhalation, oral exposure and direct contact with skin or eyes.

Keep out of reach of children.


Do not use in feeds containing pellet binding agents with the exception of Ameri-Bond 2x (calcium lignosulfonate) and Pel-Stik.

Due to known presence of bacitracin-resistant Clostridium perfringens in broiler chickens, use of BMD® 110 G should be based on susceptibility testing. If this is not possible, therapy should be based on clinical judgement and local (regional, farm level) information about susceptibility of the target bacteria.


Keep in a dry place at room temperature.

Zoetis is a trademark and BMD is a registered trademark of Zoetis or its licensors, used under license by Zoetis Canada Inc.

Zoetis Canada Inc., Kirkland QC H9H 4M7

LOT See sticker on bottom of bag

EXP. See sticker on bottom of bag





25 kg



CPN: 1198476.3

Order Desk:   800-663-8888
Technical Services Canada:   800-461-0917
Technical Services USA:   800-366-5288
Every effort has been made to ensure the accuracy of the BMD 110 G information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2020 Animalytix LLC. Updated: 2020-10-21